MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Article Abstract:
A study to identify chemokine receptors, which are important in the treatment of inflammatory diseases, was conduced. The results showed that the cytokine macrophage migration inhibitory factor is a noncognate ligand of the chemokine receptors.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Not so fast: adaptive suppression of innate immunity
Article Abstract:
A study about the T cells of the adaptive immune system, which actively suppress the cells of the innate immune system, is reported. They are observed to prevent an overzealous early innate response to severe immunopathology.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Ventilatory management of acute lung injury and acute respiratory distress syndrome. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial
- Abstracts: Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
- Abstracts: Patients turned away in vaccine shortage. Identifying and managing acute coronary syndrome. Betamethasone sodium phosphate
- Abstracts: Why immunization is essential for controlling yellow fever. Rabies vaccination and post-exposure prophylaxis. A checklist for planning flu vaccination clinics for 2006
- Abstracts: The challenge ahead. Admission units used as 'buffer zones' to meet targets